Journal article

Generation of a specific activin antagonist by modification of the activin A propeptide

Y Makanji, KL Walton, KL Chan, P Gregorevic, DM Robertson, CA Harrison

Endocrinology | OXFORD UNIV PRESS INC | Published : 2011

Abstract

Elevated activin A levels in inhibin-deficient mice promote the development of gonadal tumors and induce cachexia by reducing muscle, liver, stomach, and fat mass. Because activin A is an important regulator of tissue growth, inhibiting the actions of this TGFβ family ligand may halt or reverse pathology in diseased tissues. In this study, we modified the activin A propeptide to generate a specific activin antagonist. Propeptides mediate the synthesis and secretion of all TGFβ ligands and, for some family members (e.g. TGFβ1), bind the mature growth factor with high enough affinity to confer latency. By linking the C-terminal region of the TGFβ1 propeptide to the N-terminal region of the act..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council (NHMRC) of Australia


Funding Acknowledgements

This work was supported by Project 1006488 (to C.A.H.) and Program Grant 241000 (to D.M.R. and K.W.) from the National Health and Medical Research Council (NHMRC) of Australia. C.A.H. was supported by a NHMRC Career Development Fellowship.